Satirical Cockroach Party Reports Website Blocked Potential Free Speech and Regulatory Concerns in India
Government Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout
Pokmon Card Boom Nostalgia Speculation and HighProfile Collectors Drive MultiMillion Dollar Market
Consumer Sentiment Falls to Record Low as USIran Tensions Fuel Inflation Concerns
UK Scorches on Hottest Day of 2026 as Bank Holiday Travel Disruptions Mount
Consumer Sentiment Falls to Record Low in May as Iran Conflict Spurs Inflation Concerns
MFG Q1 2026 Earnings Strong EPS Beat of 284 Signals Solid Start to Fiscal Year
Somnigroup International Inc SGI Q1 2026 Earnings EPS Beats Estimates Stock Gains 132
HTCR Q2 2025 Earnings Stunning EPS Beat Drives DoubleDigit Stock Surge
Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss
CBRE Q1 2026 Earnings Stellar EPS Beat Underscores Resilient Business Model
SLE Q1 2026 Earnings EPS Beat Overshadowed by Revenue Concerns and Stock Slide
Beam Therapeutics Surges 7 Gene Editing Momentum Builds
Haoxi Health Technology HAO Faces Steep Decline as Selling Pressure Intensifies
Fusemachines Inc FUSE Nudges Higher as Support Holds at 135
Woodside Energy Group WDS Edges Higher at 2177 as Support and Resistance Levels Define a Consolidation Zone
Kezar Life Sciences KZR Stays Flat Key Levels and Technical Outlook
Bureau of Labor Statistics Releases Northeast Region CPI Data for April 2026
NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20
ONEOK Inc OKE Holds Steady Near Support Level Amid Modest Pullback
MSA Safety MSA Q1 2026 Earnings Solid EPS Beat Amid Steady Demand
LNSR Earnings Overview 20260522
Akari Therapeutics Q1 2026 Earnings EPS Miss Amid No Revenue Stock Surges 515
Porch Group Q1 2026 Earnings Loss Narrower Than Expected Stock Edges Higher
BNR Q3 2022 Earnings EPS Surpasses Estimates Despite Revenue Discretion and Stock Decline
Koppers Holdings Q1 2026 Earnings EPS Surges Past Estimates
MTVA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline